Company profile for Fibrocor Therapeutics

NEW Drugs in Dev: 1
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Fibrocor Therapeutics is a cutting-edge company leading the way in precision medicine, with a specific focus on fibrosis—a complex and debilitating disease. Our innovative approach revolves around tissue-specific therapeutics, aiming to revolutionize the treatment of this intricate condition. Through strategic partnerships with esteemed research institutes in Toronto, Canada, we have collected and extensively studied samples...
Fibrocor Therapeutics is a cutting-edge company leading the way in precision medicine, with a specific focus on fibrosis—a complex and debilitating disease. Our innovative approach revolves around tissue-specific therapeutics, aiming to revolutionize the treatment of this intricate condition. Through strategic partnerships with esteemed research institutes in Toronto, Canada, we have collected and extensively studied samples of diseased fibrotic tissue from various organ systems.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
Suite 1300 Toronto Ontario
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-12-09/fibrocor-therapeutics-appoints-world-leading-nephrologists-to-clinical-advisory-board-with-a-focus-on-its-lead-indication-alport-syndrome

PHARMIWEB
09 Dec 2025

https://www.prnewswire.com/news-releases/fibrocor-therapeutics-enters-into-research-and-development-collaboration-with-mcquade-center-for-strategic-research-and-development-to-advance-alport-syndrome-program-302078797.html

PR NEWSWIRE
05 Mar 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty